The NYC launchpad for global healthcare innovators. We bridge the gap between breakthrough ideas and scalable, evidence-based solutions.
Founded in New York City in 2025, Empire Health Labs (EHL) is a strategy and advisory firm built for the next generation of healthcare founders.
We partner with global teams to navigate the complexities of validation, growth, and scale. Our mission is to transform promising health technology into credible, adoptable solutions that clinicians trust and systems require.
Tailored roadmaps for entering the US and global healthcare markets with precision.
Designing and managing evidence-generation studies that satisfy rigorous stakeholders.
Positioning your narrative to align with the mandates of institutional healthcare capital.
Translating complex data into compelling value propositions for payers and providers.
Securing strategic alliances with hospital systems, labs, and pharmaceutical leaders.
Operational advisory to move from pilot phase to sustainable enterprise-wide adoption.
Moving from a high AUC score to actual clinical workflow integration.
Achieved 3 enterprise pilots in Q1 via EHL clinical pathway mapping.
Founder-led sales hitting a ceiling with major hospital GPOs.
Refined reimbursement strategy led to 210% increase in MoM revenue.
Lack of "clinical voice" in early-stage marketing collateral.
Developed evidence dossier used to secure Series A funding within 5 months.
We primarily serve Seed to Series B healthcare startup founders who have strong technology but need clinical validation, market access strategy, or expert positioning to scale.
It begins with a 45-minute diagnostic call where we evaluate your evidence base and commercial roadmap. If there's an alignment, we move into a 2-week deep dive audit.
Yes. EHL acts as a "launchpad" for international companies from Europe, Israel, and APAC looking to successfully enter and navigate the US healthcare ecosystem.
We are practitioners, not just theorists. We don't just deliver slide decks; we leverage our NYC clinician and investor network to drive actual adoption and revenue growth.
We typically onboard new partners within 14 days of the initial diagnostic call, depending on our current advisory capacity.